NCCAM cancer fellowship
This article was originally published in The Tan Sheet
The National Center for Complementary & Alternative Medicine is seeking candidates for a three-year fellowship focusing on CAM and cancer. The opportunity is offered jointly through NCCAM, the National Cancer Institute, the NIH Clinical Center and FDA's Center for Drug Evaluation & Research, and represents the first research collaboration by the parties. Fellows will conduct research on topics such as CAM botanicals in cancer and botanical-drug interactions, as well as CAM for symptom management of cancer and cancer therapy. NCCAM hopes to select a fellow by the beginning of the 2005-2006 academic year...
You may also be interested in...
The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.
Bayer notes “significant headwinds" from pandemic hitting its 2020 results likely will continue in 2021, when it t expects core earnings per share slightly below 2020 levels. While noting slumping revenues across its divisions, Bayer said an exception its consumer health business.
After US President Trump said vaccine developers could develop a COVID-19 vaccine faster if it weren't for politics, Moderna CEO Bancel said no political party has asked the company to move faster or slower.